CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY

CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY

Sixteen female patients with diabetes-associated osteoarthritis (DAOA) participated in an openlabel, randomized, cross-over study. The mean patients’ age was 65.5 (±5.4) years, the patients were obese (mean body mass index, 35.8±5.7 kg/m2 ). They suffered from durable osteoarthritis (14.5±7.6 years)...

Full description

Bibliographic Details
Main Authors:	V. S. Shirinsky, E. V. Kazygasheva, N. Yu. Kalynovskaya, I. V. Shirinsky
Format:	Article
Language:	Russian
Published:	SPb RAACI 2017-05-01
Series:	Medicinskaâ Immunologiâ
Subjects:	osteoarthritis comorbidity type 2 diabetes peroxisome proliferator-activated receptors α lipids cytokines inflammation
Online Access:	https://www.mimmun.ru/mimmun/article/view/1219

Similar Items

DIABETES-ASSOCIATED OSTEOARTHRITIS: A SYNTROPY?
by: E. V. Kazygasheva, et al.
Published: (2016-08-01)

CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF DIABETES-ASSOCIATED OSTEOARTHRITIS
by: I. V. Shirinsky, et al.
Published: (2015-03-01)

Pleiotropic effects of PPAR-α – from benchside to bedside
by: I. V. Shirinsky, et al.
Published: (2021-06-01)

Clinical and immunological features of metabolic phenotype of osteoarthritis
by: V. S. Shirinsky, et al.
Published: (2020-04-01)

INFLAMMATION AND IMMUNITY: A ROLE OF PATHOGENESIS OF OSTEOARTHRITIS
by: V. S. Shirinsky, et al.
Published: (2019-01-01)

Upregulation of hepatic VLDLR via PPARα is required for the triglyceride-lowering effect of fenofibrate
by: Yang Gao, et al.
Published: (2014-08-01)

Fenofibrate, a ligand for PPARα, inhibits aromatase cytochrome P450 expression in the ovary of mouse
by: Katsumi Toda, et al.
Published: (2003-02-01)

The acyl-CoA thioesterase I is regulated by PPARα and HNF4α via a distal response element in the promoter
by: Bikesh Dongol, et al.
Published: (2007-08-01)

Administration of a PPARα agonist increases serum apolipoprotein A-V levels and the apolipoprotein A-V/apolipoprotein C-III ratio
by: Albert E. Schultze, et al.
Published: (2005-08-01)

Combination treatment of patients with metabolic phenotype of osteoarthritis: an exploratory study
by: V. S. Shirinsky, et al.
Published: (2020-12-01)

Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation
by: Elisabetta Murru, et al.
Published: (2021-01-01)

H1-antihistamines are associated with lower prevalence of radiographic knee osteoarthritis: a cross-sectional analysis of the Osteoarthritis Initiative data
by: Ivan Shirinsky, et al.
Published: (2018-06-01)

Effect of berberine on PPARα-NO signalling pathway in vascular smooth muscle cell proliferation induced by angiotensin IV
by: Hongmei Qiu, et al.
Published: (2017-01-01)

Lipid metabolome-wide effects of the PPARγ agonist rosiglitazones⃞
by: Steven M. Watkins, et al.
Published: (2002-11-01)

The whole transcriptome effects of the PPARα agonist fenofibrate on livers of hepatocyte humanized mice
by: Montserrat A. de la Rosa Rodriguez, et al.
Published: (2018-06-01)

Nutrient-dependent phosphorylation channels lipid synthesis to regulate PPARα
by: Anne P.L. Jensen-Urstad, et al.
Published: (2013-07-01)

Attenuation of high-fat diet-induced fatty liver through PPARα activation by stevioside
by: Chang-Hao Jia, et al.
Published: (2019-06-01)

Peroxisome proliferator-activated receptors-alpha (PPAR-α) and chronic heart failure: Is there a reason to discuss the metabolic strategy of treatment?
by: I V Zhirov, et al.
Published: (2014-01-01)

Linalool is a PPARα ligand that reduces plasma TG levels and rewires the hepatic transcriptome and plasma metabolome[S]
by: Hee-jin Jun, et al.
Published: (2014-06-01)

The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function
by: Gray Elizabeth, et al.
Published: (2012-04-01)

Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression
by: Caroline C. van der Hoogt, et al.
Published: (2007-08-01)

Activation of PPARα by Oral Clofibrate Increases Renal Fatty Acid Oxidation in Developing Pigs
by: Yonghui He, et al.
Published: (2017-12-01)

Targeting Nuclear Hormone Receptors: PPARα Agonists as Potential Disease-Modifying Drugs for Rheumatoid Arthritis
by: Ivan V. Shirinsky, et al.
Published: (2011-01-01)

Prediction of PPAR-α ligand-mediated physiological changes using gene expression profiles
by: Klaus Stensgaard Frederiksen, et al.
Published: (2004-03-01)

CLINICAL EFFICACY AND SAFETY OF ADEMETIONINE IN PATIENTS WITH DIABETES-ASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
by: I. V. Shirinsky, et al.
Published: (2016-01-01)

The HIF-2α/PPARα pathway is essential for liraglutide-alleviated, lipid-induced hepatic steatosis
by: Hou Wang, et al.
Published: (2021-08-01)

Metabolism of phytol to phytanic acid in the mouse, and the role of PPARα in its regulation
by: J. Gloerich, et al.
Published: (2007-01-01)

Role of GW0742 A PPARβ/δ Agonist on Coronary Angiogenesis in Control and Diabetic Rats
by: Ensieh Salehi, et al.
Published: (2011-08-01)

Synthesis of long-chain polyunsaturated fatty acids in lactating mammary gland: role of Δ5 and Δ6 desaturases, SREBP-1, PPARα, and PGC-1
by: Maricela Rodriguez-Cruz, et al.
Published: (2006-03-01)

Functional Activation of Peroxisome Proliferator-Activated Receptor α (PPARα) by Environmental Chemicals in Relation to Their Toxicities
by: AOYAMA, TOSHIFUMI, et al.
Published: (2002)

PPARα contributes to protection against metabolic and inflammatory derangements associated with acute kidney injury in experimental sepsis
by: Takuma Iwaki, et al.
Published: (2019-05-01)

Fenofibrate reduces intestinal cholesterol absorption via PPARα-dependent modulation of NPC1L1 expression in mouse
by: Mark A. Valasek, et al.
Published: (2007-12-01)

PPARα controls the intracellular coenzyme A concentration via regulation of PANK1α gene expression1
by: Gayathri Ramaswamy, et al.
Published: (2004-01-01)

Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity
by: Ayza MA, et al.
Published: (2020-10-01)

<i>Lactobacillus plantarum</i> CQPC02 Prevents Obesity in Mice through the PPAR-α Signaling Pathway
by: Xin Zhao, et al.
Published: (2019-08-01)

Type II nuclear hormone receptors, coactivator, and target gene repression in adipose tissue in the acute-phase response
by: Biao Lu, et al.
Published: (2006-10-01)

Inhibition of FAAH confers increased stem cell migration via PPARα
by: Yvonne Wollank, et al.
Published: (2015-10-01)

Curcumin promotes AApoAII amyloidosis and peroxisome proliferation in mice by activating the PPARα signaling pathway
by: Jian Dai, et al.
Published: (2021-01-01)

COMORBIDITY, DNA METHYLATION AND AUTOIMMUNITY IN DIABETES-ASSOCIATED OSTEOARTHRITIS: AN EXPLORATORY STUDY
by: I. V. Shirinsky, et al.
Published: (2015-10-01)

AZ 242, a novel PPARα/γ agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats
by: Bengt Ljung, et al.
Published: (2002-11-01)

Cannot write session to /tmp/vufind_sessions/sess_rv31t5d1l78ung3qi7feslgs0k